[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 5, Issue 2 (12-2006) ::
3 2006, 5(2): 135-0 Back to browse issues page
Renoprotection by Telmisartan versus Benazepril in Streptozotocin Induced Diabetic Nephropathy
Salil Budhiraja , J. Singh , B R Arora , B R Arora
Abstract:   (1340 Views)
Diabetic nephropathy (DN) is one of the major causes of end stage renal disease. Angiotensin converting enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) are preferred for delaying progression of DN. This study compared the preventive renal effects of telmisartan (10 mg/kg, p.o.), an ARB that completely blocks angiotensin action, and benazepril (5 mg/kg, p.o.), an ACE inhibitor, which is a partial blocker of angiotensin II production, in an animal model of diabetic nephropathy. DN is induced by streptozotocin (50 mg/kg, i.p.) single injection in male albino rats. Biochemical parameters (creatinine clearance, urinary protein and blood urea) were significantly (p<0.01) altered in diabetic rats after 4 weeks. Telmisartan (10 mg/kg, p.o.) and benazepril (5 mg/kg, p.o.) treatment significantly (p<0.01) reduced elevated levels of blood urea and urinary protein in diabetic rats. Significant (p<0.05) difference for reduction in blood urea was present between telmisartan and benazepril after 8 weeks of diabetes. Difference between telmisartan and benazepril for reduction in proteinuria was not singnificant. Difference between telmisartan and benazepril for creatinine clearance improvement was also not significant (p>0.05). Histology revealed beneficial effects produced by both drugs. This study demonstrates telmisartan is equally renoprotective as benazepril.
Keywords: Diabetic nephropathy, STZ, Telmisartan, Benazepril
Full-Text [PDF 426 kb]   (593 Downloads)    
Article Type: Research Article |
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Budhiraja S, Singh J, Arora B R, Arora B R. Renoprotection by Telmisartan versus Benazepril in Streptozotocin Induced Diabetic Nephropathy. 3 2006; 5 (2) :135-0
URL: http://ijpt.iums.ac.ir/article-1-94-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 5, Issue 2 (12-2006) Back to browse issues page
مجله داروشناسی و درمان شناسی ایران Iranian Journal of Pharmacology and Therapeutics
Persian site map - English site map - Created in 0.08 seconds with 39 queries by YEKTAWEB 4623